about
Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell AllograftEvaluation of High Throughput Sequencing for Screening of Pathogens in Immunocompromised Patients With Suspected Infectious Disease.Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric PatientsSystematic Search for Primary Immunodeficiency in Adults With Infections
P767
Pathophysiological Explorations of Red Blood CellsImpact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin SequenceCHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.Evaluation of the Efficacy of the Sequencing Method by Gene-panelMolecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser SyndromeSickle Cell Anemia and Cerebral Microcirculation : Multimodal ExplorationStudy of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel DiseaseEvaluation of a Kit for the Prediction of the Risk of Graft Versus Host DiseaseCharacterization of Phenotype and Genotype of Early Onset Enteropathies
P859
Q55712619-19CE7C30-911A-472D-89C8-EAD29B88F33EQ55712626-978EFF33-441C-431F-84F8-A6212239E2E2Q56542365-7FFD49BD-832C-41FA-8D5C-A7FC2B109358Q59202761-57D52962-5A12-4332-8F4B-959C955949BFQ59598128-B25C7126-17BC-4277-B884-268C4CA0295CQ61749792-D2F76E2A-A8A6-4D83-8A1A-5C0C547060EBQ64854602-D741CF45-6177-4A91-AD33-9386315B893CQ67220684-F9204520-0EC2-4286-AAAA-05B6FE4B494DQ67442639-32FEC6F1-7599-475B-9107-C67B38831044Q7598948-62589E98-CE46-4813-ABA3-0E4A1A66BE80Q86811359-369C5EE2-E69E-4C3C-97A3-DA8BD149B5ABQ89433883-90950185-77BE-4C9D-B00D-BD7ED8F24676Q89574070-37B1F107-CE0E-4B7B-8134-39A14C6D16C3
P108
Q62811761-BDA4E57F-265D-4606-AA33-F0D7D7AFF44FQ66043266-796A3F7D-2334-40CE-9845-6D614ECABAF2Q66069949-9C03AFED-DC53-40CC-9451-657A43C7B1C9Q66078016-DBBC2026-6445-4642-95FC-2E4B6F8554ACQ66078753-C72D75D8-A92D-4074-B4B6-41B50417C2C1Q66081530-E5F8D551-16E7-41A5-8F59-CE31842B67A3Q66081537-E4BC24C9-B44B-4353-8A0F-32731034A49AQ66404718-AC846329-62E1-4DCF-9E03-90DD8B7FAB43Q67129648-B45C6D4B-42D5-42A8-AB38-51BD860DA79E
P859
description
facility in Paris, France
@en
name
Imagine Institute for Genetic Diseases
@en
Institut des Maladies Génétiques Imagine
@fr
type
label
Imagine Institute for Genetic Diseases
@en
Institut des Maladies Génétiques Imagine
@fr
altLabel
IHU Imagine - Institut des Maladies Génétiques
@fr
IHU Imagine
@fr
Imagine Institute
@en
prefLabel
Imagine Institute for Genetic Diseases
@en
Institut des Maladies Génétiques Imagine
@fr
P749
P269
P17
P213
0000 0004 0620 6624
P214
909144647721021499636
P2427
grid.462336.6
P269
P3016
201420829J
P571
2007-01-01T00:00:00Z
P625
Point (2.318105 48.845273)
P6773
P6782
P749
P7859
viaf-909144647721021499636